| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;95:342-350.)
© 1997 American Heart Association, Inc.
Articles |
Improved Outcome of Elderly Patients (
75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel
the Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer, and the Heiden Department of Cardiology, Bikur Cholim Hospital (S.G., S.S.), Jerusalem, Israel.
Correspondence to Shmuel Gottlieb, MD, Heiden Department of Cardiology, Bikur Cholim Hospital, PO Box 492, Jerusalem, Israel 91004. E-mail sgott{at}md2.huji.ac.il
Background The number of elderly patients experiencing acute myocardial infarction (AMI) is growing rapidly, and their hospital mortality rate remains high, although mortality after AMI declined in the 1990s with the introduction of new therapeutic modalities.
Methods and Results We compared the management, in-hospital complications, and 30-day and 1-year mortality rates in two cohorts of elderly (75 years of age) AMI patients in the coronary care units in Israel before and after the reperfusion era. The first cohort of 789 consecutive patients was from the Secondary Prevention Reinfarction Israel Nifedipine Trial registry in 1981-1983; the second 366 patients came from two prospective nationwide surveys in 1992 and 1994. Reperfusion therapies were not used in 1981-1983 but were used in 1992-1994. The 30-day mortality rate declined from 38% in 1981-1983 to 27% in 1992-1994 (odds ratio, 0.49; 95% confidence interval [CI], 0.34 to 0.71), and the cumulative 1-year mortality rate declined from 52% to 38% (hazard ratio [HR], 0.62; 95% CI, 0.50 to 0.76). In the 1992-1994 cohort, the decline in mortality was most marked in patients reperfused by thrombolysis and/or percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery but was also evident in nonreperfused patients: cumulative 1-year mortality rate was 29% in the former (HR, 0.45; 95% CI, 0.31 to 0.67) and 42% in the latter (HR, 0.60; 95% CI, 0.46 to 0.78).
Conclusions During the last decade, elderly (75 years) AMI patients experienced fewer in-hospital complications and lower 30-day and 1-year mortality rates, which declined 
30%, most markedly in reperfused patients. The favorable outcome in 1992-1994 was related to changes in patient management. Reperfusion therapy is therefore also advocated in elderly AMI patients, unless specific contraindications are present.
Key Words: aging • survival • myocardial infarction • reperfusion • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  S. Setoguchi, R. J. Glynn, J. Avorn, M. A. Mittleman, R. Levin, and W. C. Winkelmayer Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-Year Trend Analysis J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1247 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Boden and D. J. Maron Reducing Post-Myocardial Infarction Mortality in the Elderly: The Power and Promise of Secondary Prevention J. Am. Coll. Cardiol., April 1, 2008; 51(13): 1255 - 1257. [Full Text] [PDF]
|
|
|
|
 |
|
 S P Johnsen, J Videbaek, L Pedersen, R Steffensen, R Videbaek, T Niemann, T T Nielsen, and H T Sorensen Survival trends among Danish patients undergoing coronary angiography for known or suspected ischaemic heart disease: a population based follow up study, 1992-2000 Heart, January 1, 2006; 92(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Stenestrand and L. Wallentin Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment-Elevation Myocardial Infarction: One-Year Follow-up of a Large Prospective Cohort Arch Intern Med, April 28, 2003; 163(8): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Williams, J. L. Fleg, P. A. Ades, B. R. Chaitman, N. H. Miller, S. M. Mohiuddin, I. S. Ockene, C. B. Taylor, and N. K. Wenger Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients >=75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention Circulation, April 9, 2002; 105(14): 1735 - 1743. [Full Text] [PDF]
|
|
|
|
|
|
I M Barbash, S Behar, A Battler, D Hasdai, V Boyko, S Gottlieb, and J Leor Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities Heart, August 1, 2001; 86(2): 145 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.J Bowker, R.M Turner, D.A Wood, T.L Roberts, N Curzen, M Gandhi, S.G Thompson, and K.M Fox A national Survey of Acute Myocardial Infarction and Ischaemia (SAMII) in the U.K.: characteristics, management and in-hospital outcome in women compared to men in patients under 70 years Eur. Heart J., September 1, 2000; 21(17): 1458 - 1463. [Abstract] [PDF]
|
|
|
|
|
|
C T Hourigan, D Mountain, P E Langton, I G Jacobs, I R Rogers, G A Jelinek, and P L Thompson Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time Heart, August 1, 2000; 84(2): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Gottlieb, U Goldbourt, V Boyko, D Harpaz, L Mandelzweig, Z Khoury, S Stern, S Behar, and for the SPRINT and Israeli Thrombolytic Survey Gro Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994 Eur. Heart J., February 2, 2000; 21(4): 284 - 295. [Abstract] [PDF]
|
|
|
|
|
|
S. Gottlieb, V. Boyko, D. Harpaz, H. Hod, M. Cohen, L. Mandelzweig, Z. Khoury, S. Stern, S. Behar, and for the Israeli Thrombolytic Survey Group Long-term (three-year) prognosis of patients treated with reperfusion or conservatively after acute myocardial infarction J. Am. Coll. Cardiol., July 1, 1999; 34(1): 70 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Waldecker, W. Waas, W. Haberbosch, R. Voss, H. Heizmann, and H. Tillmanns Long-term follow-up after direct percutaneous transluminal coronary angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1320 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Eldar, M. Canetti, Z. Rotstein, V. Boyko, S. Gottlieb, E. Kaplinsky, and S. Behar Significance of Paroxysmal Atrial Fibrillation Complicating Acute Myocardial Infarction in the Thrombolytic Era Circulation, March 17, 1998; 97(10): 965 - 970. [Abstract] [Full Text] [PDF]
|
|